OMRF researchers found mutations in PDGF receptor beta can trigger two rare diseases.
Oklahoma researchers zero in on cause of blood disorder
New findings could help scientists develop treatments for the condition known as ITP.
Q BioMed Inc. finalizes license agreement with OMRF, RGCB
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Researchers make new insights into birth defects, infertility
Abnormal numbers of chromosomes—known as aneuploidy—are a common cause of genetic disorders and birth defects.
OMRF scientist discovers signal that drives cell division
An enzyme called PP1 tells the cells it’s the right time to divide.
New publication marks a first for OMRF MS collaborators
OMRF researchers another step in translational medicine.